After treatment. Psychosocial issues in gynecologic cancer survivorship
β Scribed by Sarah S. Auchincloss
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 885 KB
- Volume
- 76
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
The woman treated for gynecologic cancer must contend with a challenging group of issues in her efforts to recover psychologically in the months and years after treatment: chance of dying, changed self-perception, treatment-related menopause, impaired or lost fertility, sexual dysfunction, and relationship problems must all be addressed. Psychological and sexual problems after treatment and quality-of-life issues for the gynecologic cancer patient have been the subjects of increasing research in the past few years, and a brief literature review is provided. However, the literature contains few descriptive studies regarding the relevant clinical issues faced by the woman treated for gynecologic cancer who has been free of disease for a period1 of months to years, particularly the younger patient. As the pool of successfully treated women grows, these issues will merit further exploration. The oncology clinician can play a continuing role in offering support, suggestions, and referral in the years of treatment follow-up.
An overview of the clinical issues relevant to the gynecologic cancer survivor iis provided, with reference to the literature and with suggestions for clinical management for the oncology clinician.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND. Few studies have evaluated lymphedema after gynecological cancer treatment. The aim of this research was to establish prevalence, correlates, and supportive care needs of gynecological cancer survivors who develop lymphedema. ## METHODS. In 2004, a populationβbased cro
## BACKGROUND. The aim of this study was to collect information about the psychosocial situation of young patients after multimodality therapy for bone cancer. ## METHODS. Selection criteria for patients were ages 15-30 years, tumor localization at the extremities, and an interval of at least 1